BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
NLR showed a significant association with CVD mortality in patients who died before 70 years. First, results should be presented in the manuscript as statistically significant. Second, it would be worthwhile to highlight that these findings contribute to expand the recent evidence that NLR represents a simple and reliable prognostic biomarker and it has proven its predictive accuracy in patients with vascular diseases affecting either the brain (Ref. Neutrophil-to-lymphocyte ratio improves outcome prediction of acute intracerebral hemorrhage. J Neurol Sci. 2018; Neutrophil-to-Lymphocyte Ratio in Acute Cerebral Hemorrhage: a System Review. Transl Stroke Res. 2019) or the heart (Ref. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008; Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clin Appl Thromb Hemost 2014). Please, discuss this point, as suggested.
The manuscript may be enriched by discussing more extensively the potential pathophysiological mechanisms underlying the study findings.
REVIEWER

Karl Kelsey
Brown Univiersity, USA REVIEW RETURNED 13-May-2019
GENERAL COMMENTS
This is a straightforward manuscript describing a prospective study of leukocyte count and mortality in the EPIC cohort. It is well conducted and well analyzed. I have very minimal comments:
They authors might consider adding the age of individuals studied to the Abstract. There are several instances where the prose is awkward, although nothing that mandates editing. In the discussion of the NLR the authors might also consider adding a comment that this biomarker may be especially sensitive to the suppressive action of particularly activated myeloid cells; that is, the NLR may reflect the phenotypic action of a disease process and thus be less evident in a prospective setting. I would suggest a quick analysis to check whether the NLR predicition changes when they consider time to event -the idea being that the blood draws closer to event are more influenced by the disease process.
REVIEWER
Paul Welsh
University of Glasgow, UK REVIEW RETURNED 15-May-2019
GENERAL COMMENTS
This is generally a nice and fairly simple analysis using a large existing dataset. The direction of association is broadly in line with expectations from the literature. The manuscript is well written. I do have a few comments the authors should consider 1. Tests for interaction are mentioned in the methods and the results. The p-values from these tests are never mentioned. They should be included as evidence of interaction (Table 3) . 2. Table 3 should be repeated by categories of BMI to support the main narrative 3. Table 4 should, in my opinion, be dropped from the manuscript. It relies on arbitrary categories of WBC (beyond the tertiles you already define) and has very small event numbers. It is also not clear if the hazard ratios quoted come from a model that allows for interactions, or whether each strata was modelled individually. For a cohort of this size, a multi-stratification approach is probably suboptimal. 4. Results from the mediation analysis -including 95% CI -should be described more fully. 5. Current list of adjustment variables is somewhat limited. I am not concerned too much about adjusting for lipids. However, blood pressure should probably be adjusted for. 6. I am not clear how deaths were classified as subtypes from the death certificates: codings, primary/contributing causes etc 7. The strengths and limitations bullet points could be more useful with respect to discussion of causal inference from observational data, repeated measures of WBC count etc. 8. The current reference list is incomplete with respect to the investigation of WBCs and differential counts with mortality. For instance our recent paper in UK Biobank is very large, general population based, uses differential counts, and probably should be mentioned and discussed in the context of your findings. (Welsh et al, ATVB, 2018, PMID: 29699973). 9. "Several previous studies have reported that white blood cell count was associated with mortality even after adjusting for smoking. This is not fully consistent with our analysis in healthy population. In our study, the associations between total WBC count and mortality was attenuated when smoking was incorporated into the model." I disagree with this statement; if you want to make it, you would need to repeat table 2 and show that WBCs were not associated with death after adjusting for smoking as well as other covariates. 10. "WBC count may play a partially mediate role on the pathway between smoking and mortality risk, and between obesity and mortality." -abstract and discussion -please sense check. I would also suggest that your data show that some of the effect of WBCs on mortality is mediated by smoking and BMI. To test whether WBCs mediate the smoking effect would require smoking to be the primary exposure of interest (and adjust for WBCs). Its important the primary exposure of interest is clear here.
VERSION 1 -AUTHOR RESPONSE
Reviewer(s)' Comments to Author:
Reviewer: 1 Reviewer Name: Simona Lattanzi Institution and Country: Marche Polytechnic University, Italy Competing interests: None declared Please leave your comments for the authors below This is a longitudinal study aimed to explore the associations between total WBC and its subtypes with the risk of all-cause, cancer and CVD mortality. A total of 14,433 participants were included, who were followed up for an average of 15.8 years. Higher counts of total WBC and its subtypes were found to be positively associated with a higher risk of all-cause mortality. Furthermore, the highest risk of all-cause mortality was observed in ever smokers with higher BMI.
The study is overall interesting and well-written, and addressed a topic for which limited data are available. Nonetheless, some points need to be implemented.
NLR showed a significant association with CVD mortality in patients who died before 70 years. First, results should be presented in the manuscript as statistically significant. Second, it would be worthwhile to highlight that these findings contribute to expand the recent evidence that NLR represents a simple and reliable prognostic biomarker and it has proven its predictive accuracy in patients with vascular diseases affecting either the brain (Ref. The manuscript may be enriched by discussing more extensively the potential pathophysiological mechanisms underlying the study findings.
Response: Thank you for the positive comments. In this study, NLR has not been associated with the total mortality, the main outcome we presented in this study, although we found statistically significant association with CVD mortality in patients who died before 70 years. The number of CVD outcome in this category is small and the results may not be robust as the main outcome. Therefore, we did not present this result in our manuscript. Our study conducted in the general population is different from the suggested references, in which study patients with cardiovascular disease or cerebrovascular disease such as acute intracerebral haemorrhage, acute coronary syndrome and coronary artery disease are the study participants of interest. This is reasonable because NLR is a sensitive biomarker for acute inflammation.
As suggested by the first and the second reviewer, we have done additional analysis to check whether the association of NLR with total mortality changes when the follow up time changes (time to event). Interestingly, NLR is significantly associated with total mortality in one and five years follow up. This significant association, however, disappeared when the follow up time was six years and ten years. The average follow up time for the total cohort is 15.8 years. Therefore, the NLR was not associated with the total mortality in the main analysis. This is also consistent with the results when we considered patients died before 70 years as the outcome. We added more discussion on this issue on Page 13-14.
Reviewer: 2 Reviewer Name: Karl Kelsey Institution and Country: Brown Univiersity, USA Competing interests: none declared
Please leave your comments for the authors below
Response: Thank you for the positive comments. We added the age of individuals studied to the Abstract now. We have further read and revised the text as the reviewer pointed out.
Moreover, we have done the analysis suggested by the reviewer to check whether the NLR prediction changes when we consider the time to event. Specifically, we analysed one year follow up, five years follow up, six years follow up and ten years follow up. The NLR was significantly associated with total mortality in one year and five years follow up. This significant association, however, disappeared in six and ten years follow up. This is consistent with what the reviewer pinpointed. Therefore, we added more comments as suggested on Page 13-14.
Reviewer: 3 Reviewer Name: Paul Welsh Institution and Country: University of Glasgow, UK Competing interests: None declared Please leave your comments for the authors below This is generally a nice and fairly simple analysis using a large existing dataset. The direction of association is broadly in line with expectations from the literature. The manuscript is well written. I do have a few comments the authors should consider 1. Tests for interaction are mentioned in the methods and the results. The p-values from these tests are never mentioned. They should be included as evidence of interaction (Table 3) . Response: We have conducted quite a few tests for interaction between smoking status and WBC/subtype; and smoking intensity and WBC/subtype. It is difficult to show p values of such results in the table because many categories were included. Furthermore, our smoking stratified analysis have further verified the significant interactions.
2. Table 3 should be repeated by categories of BMI to support the main narrative Response: As the interaction test was not significant, we did not report the results stratified by BMI separately.
3. Table 4 should, in my opinion, be dropped from the manuscript. It relies on arbitrary categories of WBC (beyond the tertiles you already define) and has very small event numbers. It is also not clear if the hazard ratios quoted come from a model that allows for interactions, or whether each strata was modelled individually. For a cohort of this size, a multi-stratification approach is probably suboptimal. Response: The categories were not arbitrary but based on clinical standard ranges. We agree that the small number event number in some categories may restrict the value of Table 4 . The purpose of this table is to show the joint effect of WBC and BMI which is the simple and straightforward way to display. We added more explanations for the prior conditions as the reviewer suggested.
4. Results from the mediation analysis -including 95% CI -should be described more fully. Response: We included the 95% CI now.
5. Current list of adjustment variables is somewhat limited. I am not concerned too much about adjusting for lipids. However, blood pressure should probably be adjusted for. Response: We agree that blood pressure should be adjusted for. When blood pressure was included in the model, the results for total blood cell count or differential blood cell count did not change materially, therefore we did not include it in the final model. 6. I am not clear how deaths were classified as subtypes from the death certificates: codings, primary/contributing causes etc. Response: Date and cause of death for the deceased persons are obtained through linkage with Statistics Netherlands, the most reliable source available in The Netherlands. Meanwhile, the way causes of deaths and overall mortality were ascertained in EPIC-NL that has been published previously (Gunter MJ, et al. 2017; PMID: 28693038) .
7. The strengths and limitations bullet points could be more useful with respect to discussion of causal inference from observational data, repeated measures of WBC count etc. Response: We included the bullet points for strengths and limitations, which was suggested by the editor as well. It has been added after the Abstract.
8. The current reference list is incomplete with respect to the investigation of WBCs and differential counts with mortality. For instance our recent paper in UK Biobank is very large, general population based, uses differential counts, and probably should be mentioned and discussed in the context of your findings. (Welsh et al, ATVB, 2018, PMID: 29699973) . Response: Thank you for suggestion of relevant references which we missed to include. We added more discussion in our study on Page 13 regarding the new reference.
